Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.

MLA

Klaassen, Remy, et al. “Pathological Validation and Prognostic Potential of Quantitative MRI in the Characterization of Pancreas Cancer: Preliminary Experience.” Molecular Oncology, vol. 14, no. 9, Sept. 2020, pp. 2176–89. EBSCOhost, https://doi.org/10.1002/1878-0261.12688.

APA

Klaassen, R., Steins, A., Gurney, C. O. J., Bijlsma, M. F., Tienhoven, G., Engelbrecht, M. R. W., Eijck, C. H. J., Suker, M., Wilmink, J. W., Besselink, M. G., Busch, O. R., Boer, O. J., Vijver, M. J., Hooijer, G. K. J., Verheij, J., Stoker, J., Nederveen, A. J., & Laarhoven, H. W. M. (2020). Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience. Molecular Oncology, 14(9), 2176–2189. https://doi.org/10.1002/1878-0261.12688

Chicago

Klaassen, Remy, Anne Steins, Champion, Oliver J. Gurney, Maarten F. Bijlsma, Geertjan Tienhoven, Marc R. W. Engelbrecht, Casper H. J. Eijck, et al. 2020. “Pathological Validation and Prognostic Potential of Quantitative MRI in the Characterization of Pancreas Cancer: Preliminary Experience.” Molecular Oncology 14 (9): 2176–89. doi:10.1002/1878-0261.12688.